Clinical outcomes after conversion from brand-name tacrolimus (Prograf) to a generic formulation in renal transplant recipients: A retrospective cohort study

Kwaku Marfo, Samuel Aitken, Enver Akalin

Research output: Contribution to journalArticle

8 Citations (Scopus)
Original languageEnglish (US)
Pages (from-to)484-488
Number of pages5
JournalP and T
Volume38
Issue number8
StatePublished - Aug 2013

Fingerprint

Tacrolimus
Names
Cohort Studies
Retrospective Studies
Kidney
Transplant Recipients

ASJC Scopus subject areas

  • Pharmacology (medical)

Cite this

Clinical outcomes after conversion from brand-name tacrolimus (Prograf) to a generic formulation in renal transplant recipients : A retrospective cohort study. / Marfo, Kwaku; Aitken, Samuel; Akalin, Enver.

In: P and T, Vol. 38, No. 8, 08.2013, p. 484-488.

Research output: Contribution to journalArticle

@article{7bb34d8bdc1b49d6897c2c2e63f92ea1,
title = "Clinical outcomes after conversion from brand-name tacrolimus (Prograf) to a generic formulation in renal transplant recipients: A retrospective cohort study",
author = "Kwaku Marfo and Samuel Aitken and Enver Akalin",
year = "2013",
month = "8",
language = "English (US)",
volume = "38",
pages = "484--488",
journal = "Hospital Therapy",
issn = "1052-1372",
publisher = "MediMedia USA Inc.",
number = "8",

}

TY - JOUR

T1 - Clinical outcomes after conversion from brand-name tacrolimus (Prograf) to a generic formulation in renal transplant recipients

T2 - A retrospective cohort study

AU - Marfo, Kwaku

AU - Aitken, Samuel

AU - Akalin, Enver

PY - 2013/8

Y1 - 2013/8

UR - http://www.scopus.com/inward/record.url?scp=84882596047&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84882596047&partnerID=8YFLogxK

M3 - Article

AN - SCOPUS:84882596047

VL - 38

SP - 484

EP - 488

JO - Hospital Therapy

JF - Hospital Therapy

SN - 1052-1372

IS - 8

ER -